Skip to Main Content

Advertisement

Skip Nav Destination

Glasdegib with Low-Dose Cytarabine: A New Upfront Option for the Vulnerable AML Patient

Clin Cancer Res (2019) 25 (20): 6015–6017.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Tucker Lemos
  • Akil Merchant
Frontiers in Oncology (2022) 12
  • Cyril Fersing
  • Fanny Mathias
Acta Pharmaceutica (2022) 72 (1): 9.
  • Jonathan Feld
  • Lewis R. Silverman
  • Shyamala C. Navada
Clinical Lymphoma Myeloma and Leukemia (2021) 21 (4): e415.
  • Je-Hwan Lee
  • Stefan Faderl
  • John M. Pagel
  • Chul Won Jung
  • Sung-Soo Yoon
  • Animesh D. Pardanani
  • Pamela S. Becker
  • Howard Lee
  • Jeongeun Choi
  • Kyoungjune Lee
  • Minkyoung Kim
  • Jorge E. Cortes
Blood Advances (2020) 4 (9): 2032.
Close Modal

or Create an Account

Close Modal
Close Modal